Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1976 1
1977 4
1978 2
1979 4
1980 2
1981 4
1982 2
1983 5
1984 3
1985 1
1986 4
1988 6
1989 4
1990 1
1991 3
1992 1
1994 1
1995 2
1996 1
1997 5
1998 2
1999 4
2000 3
2001 12
2002 12
2003 11
2004 8
2005 6
2006 14
2007 14
2008 14
2009 26
2010 15
2011 20
2012 20
2013 18
2014 19
2015 28
2016 15
2017 18
2018 16
2019 11
2020 12
2021 11
2022 16
2023 24
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Results by year

Filters applied: . Clear all
Page 1
Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.
Dréno B, Layton AM, Troielli P, Rocha M, Chavda R. Dréno B, et al. Eur J Dermatol. 2022 Jul 1;32(4):445-450. doi: 10.1684/ejd.2022.4275. Eur J Dermatol. 2022. PMID: 36301750 Review. English.
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with benzoyl peroxide (BPO) 2.5%. Adapalene 0.3%/BPO 2.5% is approved for use for moderate-to-severe acne with proven efficacy, good …
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with …
Management of Acne Vulgaris: A Review.
Eichenfield DZ, Sprague J, Eichenfield LF. Eichenfield DZ, et al. JAMA. 2021 Nov 23;326(20):2055-2067. doi: 10.1001/jama.2021.17633. JAMA. 2021. PMID: 34812859 Review.
Topical therapies such as retinoids (eg, tretinoin, adapalene), benzoyl peroxide, azelaic acid, and/or combinations of topical agents are first-line treatments. ...CONCLUSIONS AND RELEVANCE: Acne vulgaris affects approximately 9% of the population worldwide and appr …
Topical therapies such as retinoids (eg, tretinoin, adapalene), benzoyl peroxide, azelaic acid, and/or combinations of topical …
Benzoyl Peroxide.
[No authors listed] [No authors listed] 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000481 Free Books & Documents. Review.
Topical benzoyl peroxide has not been studied during breastfeeding. Because only about 5% is absorbed following topical application, it is considered a low risk to the nursing infant.[1][2] Ensure that the infant's skin does not come into direct contact with the are …
Topical benzoyl peroxide has not been studied during breastfeeding. Because only about 5% is absorbed following topical applic …
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl peroxide (BPO) 3.1%/adapalene 0.15% (IDP-126) gel for the treatment of acne. ...CONCLUSIONS: Once-daily treatment with the no …
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl …
Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
Dréno B, Bissonnette R, Gagné-Henley A, Barankin B, Lynde C, Kerrouche N, Tan J. Dréno B, et al. Am J Clin Dermatol. 2018 Apr;19(2):275-286. doi: 10.1007/s40257-018-0352-y. Am J Clin Dermatol. 2018. PMID: 29549588 Free PMC article. Clinical Trial.
OBJECTIVES: Our objective was to evaluate the efficacy of adapalene 0.3%/benzoyl peroxide 2.5% gel (A0.3/BPO2.5) in atrophic acne scar formation in patients with acne. ...
OBJECTIVES: Our objective was to evaluate the efficacy of adapalene 0.3%/benzoyl peroxide 2.5% gel (A0.3/BPO2.5) in atr …
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
McKeage K, Keating GM. McKeage K, et al. Am J Clin Dermatol. 2008;9(3):193-204. doi: 10.2165/00128071-200809030-00010. Am J Clin Dermatol. 2008. PMID: 18429651 Review.
Clindamycin 1%/benzoyl peroxide 5% (BenzaClin) is a combination gel indicated for use twice daily, or as directed by a physician, for the topical treatment of inflammatory and noninflammatory lesions of acne vulgaris. ...In the reduction of noninflammatory le …
Clindamycin 1%/benzoyl peroxide 5% (BenzaClin) is a combination gel indicated for use twice daily, or as directed by a …
Formulation Of Benzoyl Peroxide Microsponge-Based Transdermal Gel For Acne Infection And Its Evaluation.
Raut SS, Singh NR, Rane BR, Jain AS. Raut SS, et al. Pharm Nanotechnol. 2023 Sep 8. doi: 10.2174/2211738511666230908162410. Online ahead of print. Pharm Nanotechnol. 2023. PMID: 37694777
BACKGROUND: Benzoyl peroxide is a peroxide with antibacterial, irritating, keratolytic, comedolytic, and anti-inflammatory properties. ...Treatment for acne vulgaris involves the use of benzoyl peroxide. OBJECTIVE: The research is aimed at study …
BACKGROUND: Benzoyl peroxide is a peroxide with antibacterial, irritating, keratolytic, comedolytic, and anti-inflammat …
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT, Plosker GL. Warner GT, et al. Am J Clin Dermatol. 2002;3(5):349-60. doi: 10.2165/00128071-200203050-00007. Am J Clin Dermatol. 2002. PMID: 12069641 Review.
Clindamycin/benzoyl peroxide gel has demonstrated clinical efficacy in the treatment of acne vulgaris through both antibacterial and anti-inflammatory means. ...Clindamycin/benzoyl peroxide gel applied twice daily was well tolerated in cl …
Clindamycin/benzoyl peroxide gel has demonstrated clinical efficacy in the treatment of acne vulgaris through both anti …
Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged 12 years.
Keating GM. Keating GM. Am J Clin Dermatol. 2011 Dec 1;12(6):407-20. doi: 10.2165/11208170-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967116 Review.
In three 12-week trials in patients aged 12 years with moderate acne, success rates were significantly higher with adapalene 0.1%/benzoyl peroxide 2.5% gel than with adapalene 0.1% gel or benzoyl peroxide 2.5% gel alone, and combin …
In three 12-week trials in patients aged 12 years with moderate acne, success rates were significantly higher with adapalene 0.1%/benzoyl …
406 results